Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode

Analytica Chimica Acta

Volumn 887, Issue , 2015, Pages 118-126

  Peralbo Molina, A ^a   Calderon Santiago M ^a   Priego Capote, F ^a   Jurado Gamez B ^a   Luque de Castro, M D ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Exhaled breath condensate; Exhaled breath condensate metabolome; Gas chromatography; Mass spectrometry; Metabolomics; Profiling

Indexed keywords

AMIDES; BODY FLUIDS; CONDENSATE TREATMENT; DRUG PRODUCTS; GAS CONDENSATES; HIGHER ORDER STATISTICS; LIQUIDS; MASS SPECTROMETRY; METABOLITES; PHASE SEPARATION; SOLVENT EXTRACTION; VOLATILE FATTY ACIDS;

EXHALED BREATH CONDENSATE; EXTRACTION EFFICIENCIES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LIQUID-LIQUID EXTRACTION; METABOLOMES; METABOLOMICS; PROFILING; SOLID-PHASE EXTRACTION;

GAS CHROMATOGRAPHY;

1 HEXADECANOL 2 METHYL; 13 DOCOSENAMIDE; 3,5 DI TERT BUTYL 4 HYDROXYCINNAMIC; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; BENZOIC ACID 4 ETHOXY ETHYL ESTER; BENZOIC ACID METHYL ESTER; BENZYL ALCOHOL; CINEOLE; DODECANOIC ACID 1 METHYLETHYL ESTER; EICOSENAMIDE; GLYCEROL STEARATE; GLYCIDOL STEARATE; HEDIONE; INDOLE; LAURIC ACID; METHYL STEARATE; MONOPALMITIN; MYRISTIC ACID; NONANOIC ACID; OCTANOIC ACID; OLEAMIDE; OLEIC ACID METHYL ESTER; PALMITIC ACID; PALMITIC ACID METHYL ESTER; PALMITOLEIC ACID; PARA CRESOL; STEARIC ACID; UNCLASSIFIED DRUG; UNDECANOL; UNINDEXED DRUG; VOLATILE ORGANIC COMPOUND;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); EXHALATION; EXHALED BREATH CONDENSATE; HUMAN; LIQUID LIQUID EXTRACTION; MASS FRAGMENTOGRAPHY; METABOLOMICS; NORMAL DISTRIBUTION; NORMAL HUMAN; PRIORITY JOURNAL; SKEWNESS AND KURTOSIS TEST; SOLID PHASE EXTRACTION; BREATH ANALYSIS; METABOLOME; MIDDLE AGED; PROCEDURES; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREATH TESTS; EXHALATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIQUID-LIQUID EXTRACTION; METABOLOME; METABOLOMICS; MIDDLE AGED; SOLID PHASE EXTRACTION;

EID: 84940789884     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2015.07.008     Document Type: Article

References (41)

1. Calderón-Santiago M., Priego-Capote F., Jurado-Gámez B., Luque de Castro M.D. Optimization study for metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high resolution mode. J. Chromatogr. A 2014, 1333:70-78.
2. Zhou L., Beuerman R.W. Tear analysis in ocular surface diseases. Prog. Retin. Eye Res. 2012, 31:527-550.
3. Hedlin G., Konradsen J., Bush A. An update on paediatric asthma. Eur. Respir. Rev. 2012, 21:175-185.
4. Hillas G., Loukides S., Kostikas K., Bakakos P. Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?. Curr. Med. Chem. 2009, 16:2824-2838.
5. Buszewski B., Martyna K., Ligor T., Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed. Chromatogr. 2007, 21:553-566.
6. Cao W., Duan Y. Breath analysis: potential for clinical diagnosis and exposure assessment. Clin. Chem. 2006, 52:800-811.
7. Poli D., Carbognani P., Corradi M., Goldoni M., Acampa O., Balbi B., et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir. Res. 2005, 6:71.
8. Ulanowska A., Kowalkowski T., Trawińska E., Buszewski B. The application of statistical methods using VOCs to identify patients with lung cancer. J. Breath. Res. 2011, 5:e046008.
9. Phillips M., Altorki N., Austin J.H.M., Cameron R.B., Cataneo R.N., Greenberg J., et al. Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark. 2007, 3:95-109.
10. Phillips M., Cataneo R.N., Cummin A.R.C., Gagliardi A.J., Gleeson K., Greenberg J., et al. Detection of lung cancer with volatile markers in the breath. Chest 2003, 123:2115-2123.
11. Matsumura K., Opiekun M., Oka H., Vachani A., Albelda S.M., Yamazaki K., et al. Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer. PLoS One 2010, 5:e8819.
12. Ehmann R., Boedeker E., Friedrich U., Sagert J., Dippon J., Friedel G., et al. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur. Respir. J. 2012, 39:669-676.
13. Costa C., Bucca C., Bergallo M., Solidoro P., Rolla G., Cavallo R. Unsuitability of exhaled breath condensate for the detection of herpesviruses DNA in the respiratory tract. J. Virol. Methods 2011, 173:384-386.
14. Dragonieri S., Brinkman P., Mouw E., Zwinderman A.H., Carratú P., Resta O., et al. An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls. Respir. Med. 2013, 107:1073-1078.
15. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J. Allergy Clin. Immunol. 2002, 110:28-34.
16. Mazzatenta A., Di Giulio C., Pokorski M. Pathologies currently identified by exhaled biomarkers. Respir. Physiol. Neurobiol. 2013, 187:128-134.
17. Kubáň P., Foret F. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review. Anal. Chim. Acta 2013, 805:1-18.
18. Bajtarevic A., Ager C., Pienz M., Klieber M., Schwarz K., Ligor M., et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009, 9:e348.
19. Deng C., Zhang X., Li N. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. J. Chromatogr. B 2004, 808:269-277.
20. Martin A.N., Farquar G.R., Jones A.D., Frank M. Human breath analysis: methods for sample collection and reduction of localized background effects. Anal. Bioanal. Chem. 2010, 396:739-750.
21. Phillips M. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr. B 1999, 729:75-88.
22. x in lipopolysaccharide-induced acute lung injury. Vet. J. 2012, 194:222-228.
23. de Laurentiis G., Paris D., Melck D., Maniscalco M., Marsico S., Corso G., et al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur. Respir. J. 2008, 32:1175-1183.
24. Pauling L., Robinson B., Teranishi R., Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc. Natl. Acad. Sci. U. S. A. 1971, 68:2374-2376.
25. Gordon S.M., Szldon J.P., Krotoszynski B.K., Gibbons R.D., Neill J.O. Volatile organic compounds in exhaled air from patients with lung cancer. Clin. Chem. 1985, 1282:1278-1282.
26. O'Neill H.J., Gordon S.M., O'Neill M.H., Gibbons R.D., Szidon J.P. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin. Chem. 1988, 34:1613-1618.
27. Preti G., Labows J.N., Kostelc J.G., Aldinger S., Daniele R. Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J. Chromatogr. B 1988, 432:1-11.
28. Quehenberger O., Armando A.M., Brown A.H., Milne S.B., Myers D.S., Merrill A.H., et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 2010, 51:3299-3305.
29. Martínez-Lozano P., Fernández de la Mora J. Direct analysis of fatty acid vapors in breath by electrospray ionization and atmospheric pressure ionization-mass spectrometry. Anal. Chem. 2008, 80:8210-8215.
30. Kabara J.J., Swieczkowski D.M., Conley A.J., Truant J.P. Fatty acids and derivatives as antimicrobial agents. Antimicrob. Agents Chemother. 1972, 2:23-28.
31. Henningsson Å., Björck I., Nyman M. Short-chain fatty acid formation at fermentation of indigestible carbohydrates. Food Nutr. Res. 2001, 45:165-168.
32. Vautz W., Nolte J., Fobbe R., Baumbach J.I. Breath analysis-performance and potential of ion mobility spectrometry. J. Breath. Res. 2009, 3:e036004.
33. Van Berkel J.J.B.N., Dallinga J.W., Möller G.M., Godschalk R.W.L., Moonen E.J., Wouters E.F.M., et al. A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir. Med. 2010, 104:557-563.
34. Hayet E., Fatma B., Souhir I., Waheb F.A., Abderaouf K., Mahjoub A., et al. Antibacterial and cytotoxic activity of the acetone extract of the flowers of Salvia sclarea and some natural products. Pak. J. Pharm. Sci. 2007, 20:146-148.
35. Patel N.R., Hatziantoniou S., Georgopoulos A., Demetzos C., Torchilin V.P., Weissig V., et al. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol. J. Liposome Res. 2010, 20:244-249.
36. van den Brûle S., Müller A., Fleming A.J., Smart C.C. The ABC transporter SpTUR2 confers resistance to the antifungal diterpene sclareol. Plant J. 2002, 30:649-662.
37. Stein R.A., Mead J.F. Small hydrocarbons formed by the peroxidation of squalene. Chem. Phys. Lipids 1988, 46:117-120.
38. Saito K., Shirasago Y., Suzuki T., Aizaki H., Hanada K., Wakita T., et al. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus. J. Virol. 2015, 89:2220-2232.
39. Pierce C.H., Chen Y., Dills R.L., Kalman D.A., Morgan M.S. Toluene metabolites as biological indicators of exposure. Toxicol. Lett. 2002, 129:65-76.
40. Van den Velde S., Nevens F., Van Hee P., van Steenberghe D., Quirynen M. GC-MS analysis of breath odor compounds in liver patients. J. Chromatogr. B 2008, 875:344-348.
41. Dejong C.H.C., van de Poll M.C.G., Soeters P.B., Jalan R., Olde Damink S.W.M. Aromatic amino acid metabolism during liver failure. J. Nutr. 2007, 137:1579S-1585S.